甲状腺乳头状微小癌管理的洞见
本文总结了两家日本机构对低风险甲状腺乳头状微小癌(PMC)主动监测的数据。Kuma医院1235例患者10年观察中仅8%出现肿瘤增大≥3mm、3.8%出现新发淋巴结转移;立即手术组不良事件发生率显著高于主动监测组,且10年总费用为主动监测的4.1倍。作者认为主动监测可作为低风险PMC的一线管理,老年患者是最佳候选人群。
要点
- 低风险PMC主动监测10年肿瘤增大≥3mm者仅8%,新发淋巴结转移者3.8%。
- Kuma医院立即手术组不良事件发生率显著高于主动监测组,10年总费用为主动监测的4.1倍。
- 老年(≥60岁)低风险PMC患者最不易进展,是主动监测的最佳候选人群。
核心结论
- 作者认为低风险PMC的主动监测可作为一线管理,且老年低风险PMC患者是主动监测的最佳候选人群。
研究设计与样本
- 本文汇总Kuma医院(1993年起)与东京癌研有明医院(1995年起)两家机构对低风险PMC主动监测的数据,并讨论其管理前景。
- Kuma医院系列纳入1235例PMC患者进行10年观察,另比较974例立即手术患者与1179例选择主动监测的患者。
- 癌研有明医院系列纳入230例患者共300个病灶。
- 另有51例PMC患者孕期观察及产后补救手术的分析。
主要发现
- Kuma医院1235例10年观察中,仅8%患者肿瘤增大≥3mm,3.8%出现新发淋巴结转移。
- 与临床PTC不同,PMC在老年患者(≥60岁)中最不可能生长。
- Kuma医院立即手术的974例患者不良事件发生率显著高于选择主动监测的1179例患者。
- 立即手术10年总费用(含补救手术及术后护理费用)为主动监测10年管理总费用的4.1倍。
- 51例PMC患者孕期仅8%出现肿瘤增大,产后补救手术均成功;癌研有明医院230例300个病灶中仅7%增大、1%新发淋巴结转移,且宏观或环状钙化及血供不良与疾病不进展相关。
关键数值与推荐
- PMC定义为PTC≤10mm。
- Kuma医院10年观察中肿瘤增大≥3mm者占8%,新发淋巴结转移者占3.8%。
- 癌研有明医院系列中肿瘤增大者占7%,新发淋巴结转移者占1%。
- 两系列中因进展迹象行补救手术的患者均无显著复发或死于PTC。
临床怎么用
- 作者认为低风险PMC的主动监测可作为一线管理。
- 作者指出老年低风险PMC患者是主动监测的最佳候选人群。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rapid increases in the incidence of thyroid carcinoma with stable mortality rates from thyroid carcinoma have been reported from many countries, and these increases are thought to be due mostly to the increased detection of small papillary thyroid carcinomas (PTCs), including papillary microcarcinomas (PMCs; i.e., PTCs ≤10 mm). Some researchers have suggested that small PTCs have been overdiagnosed and overtreated. In Japan, the active surveillance of patients with low-risk PMCs was initiated by Kuma Hospital (1993) and Tokyo's Cancer Institute Hospital (1995) based on the extremely higher incidences of both latent thyroid carcinomas in autopsy studies and small PTCs detected in mass screening studies using ultrasound examinations compared to the prevalence of clinical thyroid carcinomas. METHODS: The above two institutions' data are summarized regarding the active surveillance of low-risk PMCs, and future prospects for their management are discussed. RESULTS: At 10-year observations in the Kuma Hospital series of 1235 patients, only 8% and 3.8% of the PMC patients showed size enlargement by ≥3 mm and the novel appearance of node metastasis, respectively. In contrast to clinical PTC, PMCs are most unlikely to grow in older patients (≥60 years). In the Kuma Hospital series, the 974 patients who underwent immediate surgery had significantly higher incidences of unfavorable events than the 1179 patients who chose active surveillance. The total cost of immediate surgery, including the costs for salvage surgery and postoperative care for 10 years, was 4.1 times the total cost of 10-year management by active surveillance. Only 8% of the 51 PMC patients showed tumor enlargement during pregnancy, and the rescue surgeries after delivery were successful. In the Cancer Institute Hospital series of 230 patients with 300 lesions, only 7% and 1% of the patients showed size enlargement and novel node metastasis, respectively, and that institution's analysis also revealed that macroscopic or rim calcification and poor vascularity were correlated with non-progressing disease. In both series, none of the patients who underwent rescue surgery after progression signs were detected showed significant recurrence or died of PTC. CONCLUSION: Active surveillance of low-risk PMC can be the first-line management. Interestingly, older patients with low-risk PMCs are the best candidates for active surveillance.
引用
- Miyauchi A, Ito Y, Oda H, et al. Insights into the Management of Papillary Microcarcinoma of the Thyroid. Thyroid. 2017. PMID: 28629253. doi:10.1089/thy.2017.0227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。